Description
To provide market authorization holders direction on the process to be followed and information to be submitted to Health Canada regarding the potential for a proposed name to be misleading or confused with another product authorized for use in Canada with the aim of preventing medication errors.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Guidance Document for Industry - Review of Drug Brand Names | HTML | Open resource | |
| Guidance Document for Industry - Review of Drug Brand Names | HTML | Open resource |